At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,100 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
RELIEF CENSUS-EU: Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients
In Brief
An observational study for Chronic Kidney Disease-associated Pruritus. Completed, enrolled 3,100 participants across 94 sites in 7 countries.
Detailed Summary
Vifor International Inc. is seeking real-world evidence (RWE) to better understand the epidemiology, patient characteristics, and management of CKD-aP in the real-world clinical setting.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany, Italy, Portugal, Spain, Sweden, Switzerland, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedSep 2022
Enrollment StartFeb 2023
Primary CompletionJan 2024
TodayJul 2026
First PostedSep 1, 2022
Enrollment StartFeb 2, 2023
Primary CompletionJan 31, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 3.8 years ago